SuperLuckeee
Day & Swing Trader, Options/Futures & Credit Spreads
Tesla's Q3 delivery beat could fuel a gamma squeeze like the breakouts in Meta, AMD and Micron. Deliveries were 486,532 versus 463,761 expected, though Model 3/Y production of 457,387 missed the 481,279 estimate. Per @GEXEdgeIO, Tesla options were cheap, with 30-day IV near 41%, so traders loading out-of-the-money calls leave dealers short gamma and forced to buy as price rises. Holding above the prior day's $359.79 high opens a move toward $365+. x.com x.com x.comÂ
Tesla's stagnant car business and rising AI and robotics spending are squeezing current earnings before those bets have paid off. Q3 revenue was flat as auto sales slipped and regulatory credits collapsed; operating expenses rose 39%, operating income fell 56%, and EPS dropped from $0.43 to $0.24. The spend-now, profit-later strategy is testing investors' patience. x.comÂ
Tesla's 200x earnings multiple asks too much of weak current results and speculative future products. Third-quarter revenue fell 0.4% year over year and EBIT missed estimates by 25%, despite gross-margin and cash-flow beats. Robotaxis, humanoids and other future plans may have appeal, but impressive parts of the business do not make the stock worth its current price. x.com x.com x.comÂ
Tesla's stronger gross margin and automotive revenue suggest its car business is healthier than bears expected. Gross margin was 19.6% versus 17.8% expected; automotive revenue beat by over $700M, following 486,532 deliveries versus roughly 462,000 expected. Total revenue missed slightly, likely outside autos. Cybercab, unsupervised FSD and Optimus remain the key call tests. Overweight, $697 target with 80% upside. x.com x.comÂ
Tesla's stock already prices in much of its long-term AI and autonomous driving potential, while its core auto business still faces declining deliveries and margin pressure. Most analysts rate it a Moderate Buy, but that tension limits the upside. x.comÂ
Tesla's FSD attachment figures leave durable paid demand unclear because retention three to six months after the free trial is unknown. Some analysts estimate effective attachment at 30%-40%, and CFO Taneja's selective answers breed skepticism. Management's aspirational targets alone cannot justify Tesla's 175x 2027 P/E and 73x 2027 EV/EBITDA; competitors' actions, customer feedback and supplier activity also matter. Negative earnings revisions and commoditizing autonomy sustain caution. x.com … Show more
Tesla's growing Cybercab robotaxi registrations set up the next burn for short sellers. Texas registrations rose by 81 today to 544, per the state registry data shown in the chart. x.comÂ
Tesla's deteriorating earnings and automotive revenue undermine its growth story. In Q3 2026, automotive revenue fell 3% year over year, operating income fell 56%, and diluted EPS fell 44%, while total revenue was flat. x.comÂ
Tesla's falling energy and storage revenue undercuts what bulls call its next growth case. In Q3, that revenue fell 16% year over year; auto revenue fell 3%, operating income 56%, GAAP net income 43%, GAAP EPS 44% and free cash flow 62%. These terrible results make $500 a share look unlikely, even though the stock has not fallen 20%. x.com x.comÂ
Tesla's growing FSD subscriber base supports the longer-term autonomy case, but the AI build is taxing cash now. Paid FSD seats reached about 1.74 million, up 67%, while free cash flow fell 62% to $1.53 billion despite an EPS and sales beat. Post-report weakness is a discount discussion only for holders able to weather another weak cash quarter; check FSD net adds and FCF before leaning hard. A possible SpaceX combination is not part of this case. x.comÂ
Tesla's valuation is too stretched to justify buying now. Slava cites a 189x forward P/E, falling Q3 deliveries, a 1.4% operating margin and negative free cash flow; other investments look preferable. x.comÂ